Value of the 21-gene expression assay in predicting locoregional recurrence rates in estrogen receptor-positive breast cancer: a systematic review and network meta-analysis Matthew G. DaveyEoin F. CleereMichael J. Kerin Review Open access 15 April 2022 Pages: 535 - 544
Standardization of the tumor-stroma ratio scoring method for breast cancer research Sophie C. HagenaarsKiki M. H. VangangeltWilma E. Mesker Review Open access 16 April 2022 Pages: 545 - 553
Definitive results of a phase III adjuvant trial comparing six cycles of FEC-100 to four cycles of AC in women with operable node-negative breast cancer: the NSABP B-36 trial (NRG Oncology) Charles E. Geyer Jr.Hanna BandosNorman Wolmark Clinical trial 01 March 2022 Pages: 555 - 564
Correction to: Definitive results of a phase III adjuvant trial comparing six cycles of FEC-100 to four cycles of AC in women with operable node-negative breast cancer: the NSABP B-36 trial (NRG Oncology) Charles E. Geyer Jr.Hanna BandosNorman Wolmark Correction 04 May 2022 Pages: 565 - 565
Discontinuation of adjuvant endocrine therapy and impact on quality of life and functional status in older patients with breast cancer Annelieke A. LemijNienke A. de GlasJohanneke E. A. Portielje Clinical trial Open access 19 April 2022 Pages: 567 - 577
Pilot study to assess prolonged overnight fasting in breast cancer survivors (longfast) Elizabeth O’DonnellYael ShapiroJeffrey Peppercorn Clinical trial 20 April 2022 Pages: 579 - 587
False-negative rate in the extended prospective TATTOO trial evaluating targeted axillary dissection by carbon tattooing in clinically node-positive breast cancer patients receiving neoadjuvant systemic therapy Jana de BonifaceJan FrisellSteffi Hartmann Clinical trial Open access 22 April 2022 Pages: 589 - 595
Neoadjuvant therapy with doxorubicin-cyclophosphamide followed by weekly paclitaxel in early breast cancer: a retrospective analysis of 200 consecutive patients treated in a single center with a median follow-up of 9.5 years Lisi M. DredzeMichael FrigerDavid B. Geffen Clinical trial 22 April 2022 Pages: 597 - 612
Clinical factors and association with treatment modalities in patients with breast cancer and brain metastases who develop leptomeningeal metastases Akshjot PuriCharisma MylavarapuPolly Niravath Clinical trial 23 April 2022 Pages: 613 - 623
Gaps in completion and timeliness of breast surgery and adjuvant therapy: a retrospective cohort of Haitian patients with nonmetastatic breast cancer Temidayo A. FadeluParsa ErfaniTimothy R. Rebbeck Epidemiology Open access 14 April 2022 Pages: 625 - 635
RT-induced dynamic changes in the lymphocyte-to-monocyte ratio in patients with breast cancer indicate poor prognosis Dooreh KimSoong June BaeChang Ik Yoon Epidemiology 15 April 2022 Pages: 637 - 647
Prognostic significance of abdominal obesity and its post-diagnosis change in a Chinese breast cancer cohort Gary K. K. ChungWinnie YeoSuzanne C. Ho Epidemiology 16 April 2022 Pages: 649 - 658
Breast-conserving surgery with whole breast radiation therapy has a subsequent lower mood disorder incidence rate than total mastectomy in early-stage breast cancer patients: a nationwide population-based longitudinal study Yen-Hsiang LiaoJung-Nien LaiDai-Wei Liu Epidemiology 16 April 2022 Pages: 659 - 667
Risk of heart failure with preserved versus reduced ejection fraction in women with breast cancer Marilyn L. KwanRichard K. ChengJamal S. Rana Epidemiology 16 April 2022 Pages: 669 - 675
Association between weight change and breast cancer prognosis Yi-Xin ZhangZhuo-Zhi LiangZe-Fang Ren Epidemiology 18 April 2022 Pages: 677 - 684
Work ability 8 years after breast cancer: exploring the role of social support in a nation-wide survey K. VandraasR. S. FalkK. V. Reinertsen Epidemiology Open access 21 April 2022 Pages: 685 - 694
Neoadjuvant chemotherapy use trends among older women with breast cancer: 2010–2017 Hanxi ZhangJamie C. BarnerDhatri Kodali Epidemiology 21 April 2022 Pages: 695 - 705
Impact of socioeconomic status and rurality on cancer-specific survival among women with de novo metastatic breast cancer by race/ethnicity Hsiao-Ching HuangMary H. SmartGregory S. Calip Epidemiology 23 April 2022 Pages: 707 - 716